Imaavy 300 mg/1.62 ml (185 mg/ml)
Imaavy 300 mg/1.62 ml (185 mg/ml) is a medicine authorised by Swissmedic under authorisation number 69588. The authorisation holder is Janssen-Cilag AG. The medicinal product code is Biotechnological medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 18 December 2025 and the authorisation is limited until 17 December 2030. ATC code L04AL03 places the medicine in the group Immunosuppressants.
| Authorisation number | 69588 |
|---|---|
| Name | Imaavy 300 mg/1.62 ml (185 mg/ml) |
| Full name | Imaavy 300 mg/1.62 ml (185 mg/ml), Konzentrat zur Herstellung einer Infusionslösung |
| Authorisation holder | Janssen-Cilag AG |
| Medicinal product code | Biotechnological medicines |
| Dispensing category | A · Prescription, not repeatable |
| ATC code | L04AL03 |
| First authorisation | 18 December 2025 |
| Authorisation validity | 17 December 2030 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Imaavy 300 mg/1.62 ml (185 mg/ml), Konzentrat zur Herstellung einer Infusionslösung | A | 18 December 2025 |
| 2 | Imaavy 1200 mg/6.5 ml (185 mg/ml), Konzentrat zur Herstellung einer Infusionslösung | A | 18 December 2025 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 1 | Durchstechflasche(n) | L04AL03 | 07.15.0. | A |
| 2 | 1 | Durchstechflasche(n) | L04AL03 | 07.15.0. | A |
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is Imaavy 300 mg/1.62 ml (185 mg/ml) authorised in Switzerland?
Yes. Imaavy 300 mg/1.62 ml (185 mg/ml) is authorised by Swissmedic under authorisation number 69588, data as of 01 September 2026. The authorisation is limited until 17 December 2030.
Which dispensing category does Imaavy 300 mg/1.62 ml (185 mg/ml) have?
Imaavy 300 mg/1.62 ml (185 mg/ml) is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of Imaavy 300 mg/1.62 ml (185 mg/ml)?
The authorisation holder is Janssen-Cilag AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.